Literature DB >> 35332398

Extramural venous invasion (EMVI) revisited: a detailed analysis of various characteristics of EMVI and their role as a predictive imaging biomarker in the neoadjuvant treatment response in rectal cancer.

Emre Altinmakas1,2, Hakan Dogan1, Orhun Cig Taskin3, Emre Ozoran4, Dursun Bugra4, Volkan Adsay3, Emre Balik4, Bengi Gurses5.   

Abstract

PURPOSE: To assess whether size, diameter, and large vein involvement of MR-detected extramural venous invasion (MR-EMVI) have an impact on neoadjuvant therapy response in rectal adenocarcinoma.
METHODS: 57 patients with locally advanced rectal adenocarcinoma scanned with MRI before and after neoadjuvant therapy were included. Two abdominal radiologists evaluated the images with special emphasis on EMVI, on initial staging and after neoadjuvant treatment. The sensitivity and specificity of MRI for detection of rest EMVI were determined. The association of various MR-EMVI characteristics including number, size, and main vein involvement with treatment response was investigated. In subjects with discordance of radiology and pathology, elastin stain was performed, and images and slides were re-evaluated on site with a multidisciplinary approach.
RESULTS: At initial evaluation, 17 patients were MR-EMVI negative (29.8%) and 40 were MR-EMVI positive (70.2%). Complete/near-complete responders had less number (mean 1.45) and smaller diameter of MR-EMVI (mean 1.8 mm), when compared with partial responders (2.54 and 3.3 mm; p < 0.005). The sensitivity of MRI for rest EMVI detection was high, specificity was moderate, and in one patient elastin stain changed the final decision. In five patients with rest MR-EMVI positivity, carcinoma histopathologically had a distinctive serpiginous perivascular spread, growing along the track of vascular bundle, although it did not appear in intravascular spaces.
CONCLUSION: This study demonstrates that not only the presence, but also size and number of EMVI that may be significant clinically and thus these parameters also ought to be incorporated to the MRI evaluation and prognostication of treatment response. From pathology perspective, tumors growing alongside major vessels may also reflect EMVI even if they are not demonstrably "intravascular."
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cancer; EMVI; MRI; Rectum

Mesh:

Substances:

Year:  2022        PMID: 35332398     DOI: 10.1007/s00261-022-03495-4

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  15 in total

1.  MRI-based EMVI positivity predicts systemic recurrence in rectal cancer patients with a good tumor response to chemoradiotherapy followed by surgery.

Authors:  Min Soo Cho; Youn Young Park; Jiho Yoon; Seung Yoon Yang; Seung Hyuk Baik; Kang Young Lee; Ik Yong Kim; Nam Kyu Kim
Journal:  J Surg Oncol       Date:  2018-05-22       Impact factor: 3.454

2.  MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival.

Authors:  Xiao-Yan Zhang; Shuai Wang; Xiao-Ting Li; Ying-Ping Wang; Yan-Jie Shi; Lin Wang; Ai-Wen Wu; Ying-Shi Sun
Journal:  Radiology       Date:  2018-08-28       Impact factor: 11.105

3.  MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer.

Authors:  Beomseok Sohn; Joon-Seok Lim; Honsoul Kim; Sungmin Myoung; Junjeong Choi; Nam Kyu Kim; Myeong-Jin Kim
Journal:  Eur Radiol       Date:  2014-12-13       Impact factor: 5.315

4.  Rectal cancer: MR imaging in local staging--is gadolinium-based contrast material helpful?

Authors:  Roy F A Vliegen; Geerard L Beets; Maarten F von Meyenfeldt; Alfons G H Kessels; Etienne E M T Lemaire; Jos M A van Engelshoven; Regina G H Beets-Tan
Journal:  Radiology       Date:  2004-11-18       Impact factor: 11.105

Review 5.  Rectal cancer: review with emphasis on MR imaging.

Authors:  Regina G H Beets-Tan; Geerard L Beets
Journal:  Radiology       Date:  2004-08       Impact factor: 11.105

6.  Prognostic value of tumour regression grade in locally advanced rectal cancer: a systematic review and meta-analysis.

Authors:  J C Kong; G R Guerra; S K Warrier; A Craig Lynch; M Michael; S Y Ngan; W Phillips; G Ramsay; A G Heriot
Journal:  Colorectal Dis       Date:  2018-05-08       Impact factor: 3.788

7.  Invasion of veins by carcinoma of rectum: method of detection, histological features and significance.

Authors:  I C Talbot; S Ritchie; M Leighton; A O Hughes; H J Bussey; B C Morson
Journal:  Histopathology       Date:  1981-03       Impact factor: 5.087

8.  EMVI-positive stage II rectal cancer has similar clinical outcomes as stage III disease following pre-operative chemoradiotherapy.

Authors:  M Chand; A Bhangu; A Wotherspoon; G W H Stamp; R I Swift; I Chau; P P Tekkis; G Brown
Journal:  Ann Oncol       Date:  2014-04       Impact factor: 32.976

9.  The Relationship Between MR Demonstration of Extramural Venous Invasion and Nodal Disease in Rectal Cancer.

Authors:  Dow-Mu Koh; Neil J Smith; R Ian Swift; Gina Brown
Journal:  Clin Med Oncol       Date:  2008-04-01

Review 10.  A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases.

Authors:  Muhammed R S Siddiqui; Constantinos Simillis; Chris Hunter; Manish Chand; Jemma Bhoday; Aurelie Garant; Te Vuong; Giovanni Artho; Shahnawaz Rasheed; Paris Tekkis; Al-Mutaz Abulafi; Gina Brown
Journal:  Br J Cancer       Date:  2017-04-27       Impact factor: 7.640

View more
  2 in total

1.  Letter to the Editor: "Extramural venous invasion (EMVI) revisited: a detailed analysis of various characteristics of EMVI and their role as a predictive imaging biomarker in the neoadjuvant treatment response in rectal cancer".

Authors:  Furkan Ufuk
Journal:  Abdom Radiol (NY)       Date:  2022-06-22

Review 2.  Structured Reporting in Radiological Settings: Pitfalls and Perspectives.

Authors:  Vincenza Granata; Federica De Muzio; Carmen Cutolo; Federica Dell'Aversana; Francesca Grassi; Roberta Grassi; Igino Simonetti; Federico Bruno; Pierpaolo Palumbo; Giuditta Chiti; Ginevra Danti; Roberta Fusco
Journal:  J Pers Med       Date:  2022-08-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.